AzTrials
AzTrials

Country

Clinical Trials in Guadeloupe

Studies with at least one site in Guadeloupe. Open a trial for its sites in Guadeloupe, who to contact and who can take part.

112 registered studies

In numbers

Open to volunteers
39
Active
42
With results posted
4
All registered
112

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 39

Completed, with results posted

All –
  • Sickle Cell Disease

    SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)

    • Completed
    • Age: 18 years and older
    • Phase 2
    • Pill or oral medicine
    • Results posted

    The purpose of this phase IIb, international, multicentre, double-blind, randomised, placebo-controlled study is to determine the effect of hydroxycarbamide on albuminuria after 6 months of treatment in SCD adult patients.

    Trial name
    SIKAMIC (NCT03806452)
    Testing
    Hydroxycarbamide
    Where
    21 sites in Côte d’Ivoire, France and 4 more
    Volunteers
    86 people
    Sponsor
    Theravia
    Can I take part? SIKAMIC
  • Chikungunya Virus Infection

    Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

    • Completed
    • Age: 18 to 60 years
    • Phase 2
    • Vaccines
    • Injection or infusion
    • Results posted

    This is a multicenter, randomized, placebo-controlled, double-blind study to evaluate the safety and immunogenicity of a 2-injection vaccine Chikungunya virus (CHIKV) virus-like particle vaccine (CHIKV VLP) in healthy adults.

    Trial name
    NCT02562482
    Testing
    VRC-CHKVLP059-00-VP, VRC-PBSPLA043-00-VP
    Where
    6 sites in Dominican Republic, Guadeloupe and 3 more
    Volunteers
    400 people, healthy volunteers welcome
    Sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)
    Can I take part? NCT02562482
  • Sickle Cell Disease

    European Sickle Cell Disease Cohort - Hydroxyurea

    • Completed
    • Age: 2 years and older
    • Observational study
    • Results posted

    In the context of the Risk Management Plan (RMP), as requested from Addmedica by the EMEA, to collect information about long-term safety of Siklos® (hydroxycarbamide) when used in patients with Sickle Cell Disease.

    Trial name
    ESCORT-HU (NCT02516579)
    Testing
    Siklos
    Where
    60 sites in France, French Guiana and 5 more
    Volunteers
    1,906 people
    Sponsor
    Theravia
    Can I take part? ESCORT-HU
  • Vascular Diseases, Embolism and Thrombosis

    Epidemiology of Thromboembolism Disease: A Cohort Study

    • Completed
    • Age: 18 years and older
    • Observational study
    • Results posted

    The purpose of this study is to determine different risk factors of thromboembolic disease. Different points will be studied 1. do different types of thromboembolic disease (distal Deep Vein Thrombosis (DVT), proximal DVT…

    Conditions
    Vascular Diseases, Embolism and Thrombosis, Phlebitis, Venous Insufficiency
    Trial name
    OPTIMEV (NCT00670540)
    Testing
    procedure of Deep Vein Thrombosis (DVT) and PE (Pulmonary Embolism) diagnosis
    Where
    231 sites in Belgium, France and 1 more
    Volunteers
    8,256 people
    Sponsor
    University Hospital, Grenoble
    Can I take part? OPTIMEV

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in